Solta Medical, Inc. (SLTM) Tops Q3 EPS by 3c, Posts Q4 and FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts SLTM Hot Sheet
Join SI Premium – FREE
Solta Medical, Inc. (NASDAQ: SLTM) reported Q3 non-GAAP EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $26.11 million.
Solta Medical, Inc. sees Q4 2011 revenue of $32-$34 million, versus the consensus of $34.04 million.
Solta Medical, Inc. sees FY2011 revenue of $115-$117 million, versus the consensus of $115.54 million.
Solta Medical, Inc. sees Q4 2011 revenue of $32-$34 million, versus the consensus of $34.04 million.
Solta Medical, Inc. sees FY2011 revenue of $115-$117 million, versus the consensus of $115.54 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
